Vitaspring Biomedical VSBC
OTC VSBC
$0.03 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT

Vitaspring Biomedical (VSBC) Current Debt (2025)

Updated

Vitaspring Biomedical's Current Debt was $15.00 in fiscal Q1 2026 (quarter ended Apr 30, 2025).

Analysis

Vitaspring Biomedical (VSBC) Current Debt (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Eli Lilly 1,154.42 Bn 1,123.00 Bn 19.71 Bn 3.51 Bn
2 Johnson & Johnson 623.43 Bn 541.96 Bn 17.26 Bn -5.75 Bn
3 AbbVie 511.43 Bn 484.54 Bn 12.70 Bn -
4 Merck 365.39 Bn 319.77 Bn 12.21 Bn -
5 Novartis Ag 297.27 Bn 261.26 Bn 11.24 Bn 208.00 Mn
6 Astrazeneca 261.21 Bn 234.89 Bn 12.86 Bn -
7 Amgen 234.78 Bn 190.18 Bn 7.24 Bn -
8 Gilead Sciences 192.99 Bn 167.19 Bn 6.22 Bn -
9 Pfizer 171.65 Bn 118.30 Bn 10.94 Bn 64.00 Mn
10 Vitaspring Biomedical 6.21 Mn 6.19 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2025 15.00
API Access

Vitaspring Biomedical Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=VSBC&period=max&api_key=YOUR_API_KEY